DNA pharmaceutical formulations comprising citrate or triethanolamine and combinations thereof
US6387695B1 · kind B1 · utility
9Cited by
6References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 22, 1998 |
| Grant date | May 14, 2002 |
| Priority date | — |
| Expiry date | Dec 22, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to nucleic acid formulations of pharmaceutical products which comprise citrate and/or triethanolamine in concentrations which enhance stability of the nucleic acid. These formulations are suited for situations where prolonged storage occurs during the distribution and/or storage period prior to use.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.